SuppreMol completes successful Pre-IND Meeting with FDA
 |  |  |
24.01.2011
SuppreMol GmbH today announced that it has successfully completed a pre-IND meeting with the U.S. FDA for its lead compund SM101.
 | 24 kB |
| | |
24.01.2011
SuppreMol GmbH today announced that it has successfully completed a pre-IND meeting with the U.S. FDA for its lead compund SM101.
| 24 kB |